Clear pathways through the unique challenges of diagnostic development
Our full-service in vitro diagnostic management solution streamlines every aspect — and any stage — of development, from regulatory strategy and study design to expert sample and data management and submission filing.
Advancing and informing clinical decisions with innovative diagnostics
Overview
Diagnostics developers must stare down unique challenges, from managing a multitude of samples and data types to identifying and executing the right regulatory and reimbursement strategies. We can help you face and take down all of them, drawing on our deep experience in in vitro diagnostics and lab-developed tests — including point-of-care diagnostics, molecular diagnostics, immunoassays, and sample collection devices.
We provide expertise across therapeutic areas, with well-chronicled success in oncology, infectious disease, women’s health, and gastrointestinal disorders. Our diagnostics franchise managed the successful premarket approval of the first FDA-approved stool DNA noninvasive colorectal cancer screening test — just one showcase instance of how Premier Research conquers the complexities of developing novel diagnostics.
- Top-tier experience in driving diagnostic development forward. We bring domain expertise for diagnostics of all kinds, tailoring our solutions to support your specific needs at every stage of development.
- A long and versatile track record with expertise across PMA, 510(k) equivalence, de novo, and dual 510(k)/CLIA submissions. We can answer your regulatory questions, analyze your protocols, and review and support submissions.
- Experience across study settings, including labs, point-of-care facilities, Phase 1 centers, and even subjects’ homes.
- Comprehensive support, from helping you develop and execute clinical trials to providing quality control, regulatory, safety, and compliance solutions.
- Accelerated start-up. Working with a global network of sites, we can often waive the pre-study visit, accelerating timelines and lowering costs.
Comprehensive Diagnostic Solutions
Full Service IVD Management | Any Development Stage | Effective Sample Management | Various Study Settings | Expansive Data Types |
Insights
Agility and knowledge at your fingertips
How to Establish Clinical Utility of Molecular Diagnostics for Precision Medicine: 5 Tips on RCT Design
Premier Insight 280: Engineering a PMA Study
Meet the Expert
Diagnostics
Charlie Chrisawn
Charlie Chrisawn has spent his entire career focused on diagnostic development and has amassed over 15 years of experience designing and leading diagnostic trials including sample collection, validation, and utility studies. Mr. Chrisawn’s background consists of both small- and large-scale diagnostics studies, including management of all development stages of diagnostics across a range of study settings. Under Charlie’s leadership, Premier Research celebrated a milestone achievement enrolling 100,000 participants in their diagnostic studies worldwide.
Mr. Chrisawn’s programs have successfully garnered MA and 510(K) approvals, including the only FDA approved screening test for Colorectal Cancer and the first FDA cleared at-home test for COVID-19. Mr. Chrisawn has also enabled dual 510(k)/CLIA study execution and drug/device combination studies in the 505(b)(2) pathway. His expertise includes protocol and study design, domestic and international study startup, site management, sample accountability, staff training, and study closure.
Mr. Chrisawn earned a Bachelor of Science (BS) degree in Biology from Davidson College.
resources
Stay ahead of the curve by browsing our extensive library of white papers, case studies, blog posts, and more.
Ready to get started? So are we.
Drop us a line to learn more about how we can help.